Table 4.
NW (n=27) | OW (n=20) | OB (n=48) | |
---|---|---|---|
BMI (Kg/m2) | 23.0 (16.7–24.9) | 26.7 (25.2–29.1)α | 34.5 (30.0–54.7)αγ |
Age (years) | 36±15 | 45±14* | 46±11α |
Gender (W/M) | 18/9 | 11/9 | 34/14 |
Waist circumf (cm) | 78±11 | 95±7α | 107±10αγ |
TG (mmol/l) | 1.0 (0.4–2.9) | 1.8 (0.5–4.6)α | 2.1 (1.0–5.6)α |
Total-C (mmol/l) | 4.7 (3.3–7.6) | 6.2 (3.4–7.9)α | 5.2 (3.6–8.1) |
LDL-C (mmol/l) | 2.8±1.1 | 4.1±1.2α | 3.5±0.8α |
HDL-C (mmol/l) | 1.6±0.4 | 1.2±0.4α | 1.0±0.2α |
apoA-I (g/l) | 1.8±0.4 | 1.6±0.3 | 1.4±0.2α |
apoB-100 (g/l) | 0.9±0.3 | 1.1±0.3* | 1.0±0.3* |
Glucose (mmol/l) | 4.78 (3.9–5.4) | 5.3 (4.4–6.6)α | 5.5 (4.4–7.0)α |
Insulin (pmol/l) | 32.5 (13.9–66.7) | 43.0 (13.9–147.2)α | 76.4 (27.1–479.2)γ |
HOMA-IR | 0.9 (0.3–2.0) | 1.4 (0.5–15.6)* | 2.7 (0.9–20.6)αγ |
TG/ HDL-C | 1.5 (0.7–7.9) | 3.6 (0.5–15.7) | 4.4 (2.1–16.2)α |
FFA(mmol/l) | 0.5 (0.1–0.8) | 0.6 (0.1–1.1) | 0.6 (0.3–1.1) |
Adiponectin (µg/ml) | 12.6 (7.0–28.2) | 7.3 (1.9–20.6)α | 5.6 (1.9–16.4)α |
hs-CRP (mg/l) | 1.3(0.1–11.7) | 2.3 (0.2–6.2) | 3.4 (0.3–29.7)* |
Data are expressed as mean±SD or median (range) for skewed distributed data. W indicates women; M, men; BMI, body mass index; Total-C, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; apoA-I, apolipoprotein A-I; apoB, apolipoprotein B; HOMA-IR, homeostasis model assessment for insulin resistance index; FFA, free fatty acids; hs-CRP, high-sensitivity C-reactive protein. vs NW
p<0.05
p<0.01; vs OW
p<0.05
p<0.01.